
													
															
															Year
															DEALS // DEV.
															Country
															
															Therapeutic Area
															Study Phase
															Deal Type
															Product Type
															Dosage Form
															Lead Product
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Turnstone Biologics
Deal Size : Undisclosed
Deal Type : Acquisition
Turnstone Biologics Acquires Novel Cell Therapy Platform Developer, Myst Therapeutics
Details : Turnstone gains full access to this technology, the complete R&D capabilities of Myst along with existing development collaborations, and a pipeline of tumor infiltrating lymphocyte programs with the lead candidate expected to enter the clinic this year.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 20, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Turnstone Biologics
Deal Size : Undisclosed
Deal Type : Acquisition
